Find Academic Supervisors

Annette Juul Vangsted serves as a Clinical Associate Professor in the Department of Clinical Medicine at the University of Copenhagen's Faculty of Health and Medical Sciences. Her clinical specialization is in Internal Medicine with a focus on Hematology, specifically multiple myeloma. Based at Blegdamsvej 9 in Copenhagen, she maintains an active research profile with 67 documented research outputs and extensive collaborations across Nordic countries and internationally. Dr. Vangsted's research primarily centers on multiple myeloma, with particular emphasis on genetic predisposition, treatment outcomes, epidemiological patterns, and bone disease management. Her work bridges clinical practice with genetic research, examining how genetic variants influence disease risk and progression. She investigates geographical variations in myeloma incidence and outcomes, as well as novel treatment approaches for elderly patients and those with specific genetic profiles. Analysis of her recent publications reveals a clear focus on multiple myeloma across several dimensions: genetic susceptibility (including large genome-wide association studies), treatment efficacy (particularly regarding bone disease management), epidemiological patterns across Nordic countries, and specialized care for elderly populations. Her collaborative approach is evident through numerous multi-center studies involving Nordic Myeloma Study Group and international research teams. Dr. Vangsted actively participates in clinical research through the Nordic Myeloma Study Group, contributing to registry studies and clinical trials that inform treatment guidelines for multiple myeloma. Her work has significant implications for understanding disease mechanisms and improving patient outcomes, particularly in the areas of genetic risk assessment and personalized treatment approaches. She maintains strong research collaborations across Denmark, Sweden, and international institutions, with particular focus on hematological malignancies. Her laboratory and clinical research team works within the Department of Clinical Medicine's hematology division, focusing on translational research that directly impacts clinical practice for myeloma patients.

• Hematology
• Multiple Myeloma
• Cancer Genetics
• +4 more

Vilhelm Bohr is an Affiliate Professor at the Department of Cellular and Molecular Medicine , University of Copenhagen, affiliated with the Molecular Aging Program and Center for Healthy Aging . His research explores the interplay between DNA maintenance , mitochondrial biology , and aging , particularly in age-associated neurodegeneration and Alzheimer’s disease. Research Interests include: Molecular mechanisms linking NAD + metabolism to mitochondrial dysfunction and neurodegeneration Role of tau pathology in DNA damage and mitochondrial stress Impact of Aprataxin (APTX) and RECQL4 helicase defects on mitochondrial DNA integrity Pharmacological strategies to improve mitochondrial health via autophagy modulation Publications (2025-2024) span topics like NAD + biosynthesis, Werner/Rothmund-Thomson syndromes, tau nuclear functions, and mitochondrial turnover, with high citations and media attention. Collaborations extend to clinical tumor samples and CRISPR-based disease models.

• DNA Repair
• Mitochondrial Biology
• Aging
• +5 more

Jens S. Andersen is a Professor in the Department of Biochemistry and Molecular Biology at the University of Southern Denmark, where he leads research in Biomedical Mass Spectrometry and Systems Biology. His work is centered on the development and application of quantitative mass spectrometry and microscopy-based proteomics to study human cell biology, particularly the structure and function of organelles such as centrosomes, cilia, autophagosomes, and mitochondria. His research focuses on determining the protein composition and dynamic properties of cellular organelles, the roles of specific protein groups, and their contributions to biological processes and diseases. He investigates cell signaling mediated by post-translational modifications, especially within the DNA damage response, autophagy, and immune systems. His lab, the Jens S. Andersen Lab, is part of the Research Section of Biomedical Mass Spectrometry. The analysis of his recent publications reveals a strong interdisciplinary trend combining proteomics, structural biology, and cell signaling. His work spans cilia biology, RNA metabolism, DNA repair, and cancer mechanisms, with frequent use of advanced techniques like mass spectrometry, CRISPR, and live-cell imaging. The integration of systems biology approaches is evident across his research outputs. Professor, Department of Biochemistry and Molecular Biology, University of Southern Denmark Head of Research, Biomedical Mass Spectrometry and Systems Biology Principal Investigator, Jens S. Andersen Lab ORCID: 0000-0002-6091-140X While no specific scientific awards are mentioned in the provided texts, his extensive publication record in high-impact journals such as Science , Nature Communications , Molecular Cell , and EMBO Journal reflects significant scholarly contributions. He has supervised research projects and collaborated widely across Europe, though specific names of students are not listed. His research is supported by multiple ongoing projects, reflecting sustained funding and academic leadership. The Jens S. Andersen Lab operates at the intersection of proteomics and cell biology, contributing to fundamental understanding of organelle dynamics and disease mechanisms. The lab's work is highly collaborative, involving partnerships with groups in structural biology, RNA research, and cancer biology.

• Proteomics
• Quantitative Mass Spectrometry
• Cell Biology
• +11 more

Maria Timofeeva is an Associate Professor in the Epidemiology, Biostatistics and Biodemography (EBB) department at the University of Southern Denmark (SDU), with additional affiliation at the Danish Institute for Advanced Study (DIAS). She holds an Honorary Fellow position at the University of Edinburgh since December 2019. Her research focuses on cancer prevention and prediction, particularly studying the effects of environmental and genetic factors on cancer risk and progression. Dr. Timofeeva earned her Dr.sc.hum in Epidemiology from Heidelberg University (2005-2009), with a dissertation on genetic polymorphisms as risk factors for early onset lung cancer. Prior to her current position, she worked as a Statistical Geneticist at the University of Edinburgh (2013-2019) and as a Postdoctoral Fellow at the International Agency for Research on Cancer (2009-2013). Her research interests center around understanding the genetics of cancer risk through multi-omic analysis. She leads several significant projects, including the Interdisciplinary Project on Adherence to Colorectal Cancer Screening, meta-analysis of factors associated with false-positive and false-negative FOBT results (registered in PROSPERO ID: CRD42022315767), and the COlorectal Cancer screening Among RElatives (CoCARE) twin-family study in Denmark. Her methodological expertise spans observational epidemiological studies (case-control, population-based cohort studies, twin studies), meta-analysis, umbrella reviews, and multi-omics data analysis. Analysis of her recent publications reveals a strong focus on colorectal cancer genetics, with particular emphasis on genome-wide association studies, Mendelian randomization approaches, and trans-ancestry analyses. Her work frequently leverages large datasets including the UK Biobank and international consortia, with applications in cancer risk prediction and understanding gene-environment interactions. Dr. Timofeeva has an extensive publication record with 73 publications listed in her profile. Her research has been cited across multiple platforms, with mentions in news outlets, social media, and academic readership platforms like Mendeley. She is actively involved in academic service, serving as a peer reviewer for journals including BMC Cancer and Scientific Reports, and participating in conferences such as the 26th Nordic Congress of Gerontology. She also serves on evaluation committees, including with the World Cancer Research Fund International (April-May 2024). Her teaching activities include courses on evidence-based drug utilization and biostatistics, as well as supervision of research projects on gene expression in twins. Dr. Timofeeva has engaged with the public through media contributions, including an interview titled 'Jeg vil forstå, hvorfor vi får kræft' (November 15, 2021), where she discussed understanding why we get cancer.

• Cancer Epidemiology
• Genetic Risk Factors
• Colorectal Cancer
• +7 more

Kumar Somyajit is Associate Professor at the University of Southern Denmark's Department of Biochemistry and Molecular Biology. He leads research on DNA replication and genome surveillance mechanisms using mammalian cell models. Research focuses on: Metabolic regulation of DNA replication Replisome plasticity under stress Homology-directed repair mechanisms Chromatin dynamics in cancer Recipient of Lundbeck Foundation Fellowship (2021). Current projects investigate metabolic coupling to genome surveillance in cancer and development. Supervises PhD students in DNA repair and replication studies.

• DNA Repair Mechanisms
• Genome Stability
• Replication Stress
• +4 more

Kunihiko Kaneko is a Professor at the Niels Bohr Institute, University of Copenhagen, with a distinguished career in theoretical biophysics and complex systems. He received his PhD and MSc in Physics from the University of Tokyo, and has held leadership roles at the Universal Biology Institute and Center for Complex Systems Biology. PhD Physics, 1984 - University of Tokyo MSc Physics, 1981 - University of Tokyo His research spans five primary areas: Universal Biology, Evolutionary Constraints, Ecosystem Dynamics, Neural Cognition, and Universal Anthropology. He has published extensively on multi-level consistency principles, dimensional reduction in biological systems, and reciprocity between robustness and plasticity across scales. Recent publications show strong focus on microbial ecosystems (2025), evolutionary game theory (2025), neural modular architectures (2024), and dimensional reduction in cellular systems (2024). His work bridges physics and biology through dynamical systems theory applied to diverse phenomena from protocells to human societies.

• Theoretical Biophysics
• Complex Systems
• Chaos
• +6 more

Erwin Schoof is an Associate Professor at the Department of Biotechnology and Biomedicine , Technical University of Denmark. He leads the Cell Diversity Lab and focuses on advancing proteomics and mass spectrometry technologies. Expertise in single-cell proteomics , stem cell niches , and bioinformatics . Active in myelofibrosis and leukemia research , with applications in UN Sustainable Development Goals . Research Trends from 2025–2024 include: Machine learning-driven peptide sequencing (InstaNovo, InstaNexus). Single-cell resolution tools for mapping hematopoietic stem cells and tumor microenvironments . Biomarker discovery in chronic diseases and respiratory conditions . Supervision : Mentors multiple PhD students on single-cell proteomics , omics data analysis , and biotherapeutic production . Labs & Collaborations : Collaborates with international teams on plasma proteomics , 3D bioengineering , and advanced mass spectrometry workflows .

• Proteomics
• Mass Spectrometry
• Single-Cell Analysis
• +7 more

Anne-Mette Hvas is Professor and Dean at the Faculty of Health, Aarhus University, Denmark, where she leads academic and administrative initiatives in health sciences. Her role places her at the forefront of institutional strategy, research development, and interdisciplinary collaboration within clinical and translational medicine. Research Interests: Her work spans hematology, coagulation, platelet biology, neonatal hemostasis, and endocrinology. She investigates thrombotic and bleeding disorders in clinical contexts such as nephrotic syndrome, pregnancy, cancer surgery, and stroke. Her research integrates physiological, pharmacological, and clinical perspectives to improve patient outcomes. The recent publications reflect a strong focus on thrombin generation, platelet reactivity, endothelial dysfunction, and red blood cell behavior in acute and chronic conditions. These studies often involve multicenter collaborations and contribute to evidence-based practices in thromboprophylaxis, surgical safety, and stroke management. Scientific Contributions: Active research in hemostasis and thrombosis across diverse patient populations Leadership in clinical studies on anticoagulation, HIPEC, and neonatal platelet function Investigations into hormonal and cardiovascular aspects of Turner syndrome Advising and Grants: While specific advisees are not listed, her leadership in multiple funded research projects suggests mentorship of junior researchers and clinicians. She has led projects on platelet function in preterm neonates and coagulation in surgical oncology, indicating grant acquisition and team coordination capabilities. Labs and Teams: Though specific lab names are not mentioned, her work implies collaboration with clinical research teams in hematology, neonatology, oncology, and obstetrics at Aarhus University Hospital and affiliated centers.

• Hematology
• Thrombosis and Hemostasis
• Platelet Function
• +7 more

Vijay Tiwari is a Professor in the Department of Molecular Medicine at the University of Southern Denmark (SDU), where he leads research in genome biology and epigenetics. He is affiliated with the Genome Biology VIP initiative and the Danish Institute for Advanced Study (DIAS), highlighting his role in interdisciplinary and high-impact scientific inquiry. His research focuses on epigenetic regulation of gene expression, particularly in the context of cancer and neuroimmunological disorders. Key areas include transcription factor dynamics, locus control regions, promoter regulation, and the role of epigenetic mechanisms in metastasis and immune responses in the central nervous system. The recent publications demonstrate a strong trend in single-cell omics, cancer immunology, and neurodegenerative disease modeling. His work bridges molecular biology with clinical applications, particularly in understanding cancer progression and regenerative failure in ageing. Articles frequently appear in high-impact journals such as Nature Communications , Cancer Research , and Molecular Cancer . Vijay Tiwari’s scientific contributions have received significant media attention, with multiple press releases from SDU highlighting breakthroughs in cancer research, including discoveries that may halt cancer spread. His work has been covered by numerous news outlets, blogs, and social media platforms, indicating broad scientific and public impact. He has advised several early-career researchers, including Inayatullah M. and Dwivedi A.K., who appear as co-authors on multiple publications. While specific grants are not listed, his consistent output and institutional affiliations suggest active funding and collaboration networks across Europe and globally. He is associated with research teams focused on genome biology and epigenetic regulation, likely operating within collaborative labs at SDU that integrate molecular, computational, and clinical approaches to biomedical research.

• Epigenetics
• Transcription Regulation
• Cancer Biology
• +12 more

Lars Aagaard is an Associate Professor at the Department of Biomedicine - Research and Education, Aarhus University, Denmark. He is based at the Bartholin Building in Aarhus C and is actively engaged in research and teaching in the fields of gene therapy, RNA interference, and genome editing. His work focuses on developing viral vectors, particularly AAV and lentiviral vectors, for ocular gene therapy targeting retinal diseases such as age-related macular degeneration and diabetic retinopathy. His research interests include the development of Dicer-independent RNAi systems, combinatorial gene therapy using microRNA and CRISPR/Cas9, and the delivery of RNA- and protein-based therapeutics. He also teaches Genetics and Personalized Medicine and supervises postdoctoral researchers, PhD, master's, and undergraduate students. The recent publications (2022–2024) reflect a strong trend in RNAi therapeutics, viral vector engineering, and translational applications in ocular and systemic diseases. Themes include gene silencing, immune modulation, and regenerative approaches using engineered cells. Aagaard actively contributes to the scientific community as a reviewer for journals such as Nature and Molecular Therapy . He has participated in key international conferences including ARVO, ASGCT, and ESGCT, demonstrating ongoing engagement with the global gene therapy community. Supervision of postdocs, PhD, master’s, and undergraduate students Active participation in international conferences and workshops Collaborative research across institutions, including Universidade Federal de Sao Paulo He is involved in both basic and translational research, with potential for clinical applications in gene and cell therapy.

• Gene therapy
• RNA interference
• Viral vectors
• +11 more

Henrik Møller is a Professor at the Danish Center for Health Services Research , part of the Faculty of Health Sciences at Aalborg University . His work focuses on cancer epidemiology , clinical quality registries , and health services research , particularly examining prostate cancer , lung cancer , and colorectal cancer through nationwide cohort studies. Key research areas: Cancer care quality, pandemic impacts on diagnosis/treatment, socioeconomic disparities Active collaborations in Denmark and England Contributor to national and international cancer registries Recent publications analyze CT imaging trends in lung cancer detection, chemotherapy disparities in pancreatic cancer, and genetic biomarkers in gliomas. His team has released multiple datasets on figshare platforms. As a leader in health services research, Møller's work informs healthcare policy improvements through evidence-based quality indicators and development targets.

• Health Services Research
• Cancer Care
• Epidemiology
• +3 more

Sharath Anugula serves as a Guest Researcher in the Department of Cellular and Molecular Medicine at the University of Copenhagen's Faculty of Health and Medical Sciences, specifically within the Molecular Aging Program and Juel-Rasmussen Group. His research is centered at Panum Instituttet in Copenhagen. Dr. Anugula's research interests focus on the intricate relationship between mitochondrial function, genomic stability, and aging processes. His work bridges molecular biology, genetics, and systems approaches to understand fundamental mechanisms of biological aging. He has made significant contributions to understanding how DNA repair mechanisms, particularly REV1-mediated processes, interact with mitochondrial metabolism in aging contexts. His publication record demonstrates expertise in mitochondrial biology, with research examining how metabolic shifts, genomic instability, and nucleotide synthesis pathways influence aging trajectories and disease development. His work often employs both experimental and computational approaches to model complex biological systems. Anugula completed his Ph.D. at the University of Copenhagen in 2021 with research focused on nucleus-mitochondria communication in healthy aging. His scholarly output includes journal articles in Heliyon, Mitochondrion, and Experimental Gerontology, as well as book chapters on aging biology. His collaborative research network includes prominent scientists in aging research, particularly Professor Lene Juel Rasmussen, with whom he has published multiple studies examining the molecular underpinnings of aging processes.

• Mitochondrial Biology
• Aging Research
• Genomic Instability
• +3 more

Thomas Miller is an Associate Professor in the Department of Cellular and Molecular Medicine at the University of Copenhagen, working within the Molecular Aging Program. His research focuses on understanding the molecular mechanisms that maintain eukaryotic genome stability during DNA replication using genetic, biochemical, cellular, and structural techniques, including cryo-EM. Dr. Miller's primary research interests include: Molecular mechanisms of faithful genome replication How failures in genome stability maintenance cause developmental disorders and age-related diseases The role of replisomes and accessory factors in regulating chromosome replication His current research projects specifically investigate: The mechanisms and regulation of MCM helicase loading Replication-coupled DNA-protein crosslink (DPC) repair Accessory helicases in DNA replication Electron microscopy methods development through 'Reconstitution in silico' (RECONSIL) Dr. Miller's publication record demonstrates expertise across structural biology, molecular mechanisms of DNA replication, and cryo-EM techniques. His recent work spans from fundamental studies of replisome structure and function to developing new methodologies for studying DNA replication processes. His research has significant implications for understanding developmental disorders and age-related diseases including neurodegeneration and cancer. Dr. Miller is the founder of TCRM Consulting, indicating industry engagement alongside his academic work.

• Molecular Biology
• Genome Stability
• DNA Replication
• +5 more

Professor Ian David Hickson is a distinguished academic serving as Professor of Molecular Aging, Head of the Department of Cellular and Molecular Medicine, and Theme Leader in the Center for Healthy Aging at the University of Copenhagen's Faculty of Health Sciences. He also directs the DNRF Center for Chromosome Stability, a major research center funded by a 65,000,000 DKK grant from the Danish National Research Foundation. Hickson's research focuses on understanding chromosomal instability and its impact on human disease, particularly cancer, neurodegeneration, and infertility. His laboratory pioneered the discovery of ultra-fine anaphase bridges (UFBs) and identified MiDAS (Mitotic DNA Synthesis), a process that completes DNA replication at difficult-to-replicate regions. His work combines protein biochemistry, molecular/cell biology, high-resolution imaging, and single-molecule biophysical techniques to study DNA metabolism and chromosome dynamics. The most recent publications demonstrate continued leadership in chromosome biology, with research spanning DNA topology, replication stress, chromosome mechanics, and the connection between DNA repair defects and cancer immunotherapy resistance. His work shows consistent focus on fundamental mechanisms of genome maintenance with clear implications for human disease. Fellow of the Royal Society (2010) Fellow of the Academy of Medical Sciences (UK) (2010) Member of EMBO (2011) ERC Advanced Grant recipient (2012) FEBS National Lecturer Award (2013) Professor Hickson has supervised over 40 PhD students who have gone on to prominent positions worldwide, including professors at major universities, group leaders at research institutes, and scientific officers in biotech companies. His laboratory has established international collaborations across Europe, the US, and Asia, particularly with Zhejiang University in China where he holds a Qiushi Guest Professorship. He actively participates in organizing major international conferences on DNA replication and chromosome stability.

• DNA repair
• Chromosomal instability
• Bloom's syndrome
• +9 more

Mette Nyegaard is a Professor in the Department of Health Science and Technology at Aalborg University, within The Faculty of Medicine. Her research focuses on genetics and genomics, with over 25 years of expertise linking genetic variation to phenotypes in both rare and common complex diseases. She has a strong interest in gender medicine and women’s reproductive health, particularly leading Denmark’s contribution to the largest genome-wide association analysis of endometriosis. Nyegaard has held external positions, including Associate Professor roles at Aarhus University and Senior Scientist at Aarhus University Hospital. Education: PhD in Human Genetics, University of Southern Denmark (2003) MSc in Chemistry-Biotechnology, Aarhus University (1997) Research Interests: Nyegaard’s work spans genetics, genomics, GWAS, endometriosis, coronary artery disease, and personalized medicine. Her research emphasizes translating genetic insights into clinical applications, such as polygenic risk scores and biomarker development. She collaborates internationally, with projects addressing calmodulinopathies, cardiovascular genetics, and reproductive health. Projects & Grants: Lead PI on projects like 'Understanding the Genetic Architecture of Common Complex Diseases' and 'FEMaLe: Finding Endometriosis Using Machine Learning.' Co-Investigator in studies like 'The Deadly, the Deleterious, and the Dangerous – Decoding the Differential Pathogenicity among CALM1, CALM2, and CALM3.' Labs/Teams: Nyegaard’s work is part of interdisciplinary teams at Aalborg University and collaborating institutions, focusing on genomic medicine, endometriosis, and cardiovascular genomics. She contributes to initiatives like Neuroboost and the International Calmodulinopathy Registry.

• Genetics
• Genomics
• GWAS
• +4 more